Genenta Science S.p.A. (NASDAQ:GNTA) Sees Large Growth in Short Interest

Genenta Science S.p.A. (NASDAQ:GNTA) was the target of a large increase in short interest during the month of June. As of June 15th, there was short interest totalling 5,000 shares, an increase of 47.1% from the May 31st total of 3,400 shares. Based on an average daily volume of 4,300 shares, the short-interest ratio is presently 1.2 days.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reaffirmed a “buy” rating and set a $25.00 price target on shares of Genenta Science in a research report on Monday, May 13th.

Genenta Science Stock Performance

NASDAQ GNTA traded down $0.01 during trading hours on Monday, hitting $3.10. The company had a trading volume of 252 shares, compared to its average volume of 4,645. Genenta Science has a 1-year low of $2.20 and a 1-year high of $6.39. The business has a 50 day moving average of $3.25 and a 200-day moving average of $3.82.

About Genenta Science

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter.